Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice
Work
Year: 2021
Type: article
Abstract: Rigorous preclinical studies of chimeric antigen receptor (CAR) immunotherapy will require large quantities of consistent and high-quality CAR-transduced T (CART) cells that can be used in syngeneic m... more
Source: Neuro-Oncology
Institutions Neurological Surgery, University of California, San Francisco, Osaka Hospital, Osaka Red Cross Hospital, University of Pittsburgh +3 more
Cites: 40
Cited by: 11
Related to: 10
FWCI: 1.116
Citation percentile (by year/subfield): 83.45
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze
Grant ID 1R35 NS105068